Tolerance of haloperidol catalepsy.

Area of Science:

• Pharmacology
• Neuroscience
• Animal Models

Background:

• Haloperidol is a typical antipsychotic used to treat psychosis.
• Understanding drug tolerance is crucial for optimizing therapeutic efficacy.
• Rats are a common model for studying drug effects and tolerance.

Purpose of the Study:

• To investigate the development of tolerance to haloperidol in male Wistar rats.
• To characterize the time course and reversibility of haloperidol-induced catalepsy tolerance.

Main Methods:

• Daily oral administration of haloperidol (0.75 and 1.5 mg/kg) for 16 days.
• Acute injections (i.p. or p.o.) to measure catalepsy response.
• Assessment of catalepsy after a 16-day abstinence period.

Main Results:

• Animals developed tolerance to haloperidol after 16 days of daily administration.
• The cataleptic response significantly decreased in tolerant animals.
• Tolerance resolved after 16 days of drug abstinence.
• Tolerance development followed a biphasic time course with half-lives of 2.5 and 5.5 days.

Conclusions:

• Male Wistar rats exhibit significant tolerance to haloperidol's cataleptic effects with repeated administration.
• Haloperidol tolerance is reversible upon drug withdrawal.
• The biphasic nature of tolerance development suggests complex underlying neurobiological mechanisms.